Clinical Trial Update: Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment

View source ↗

Summary

A clinical trial investigating memantine for autism with cortical metrics outcome measures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Autism Spectrum Disorders | Status: WITHDRAWN